Literature DB >> 9824701

S100B, a neurotropic protein that modulates neuronal protein phosphorylation, is upregulated during lesion-induced collateral sprouting and reactive synaptogenesis.

B S McAdory1, L J Van Eldik, J J Norden.   

Abstract

Using light and electron microscopic immunocytochemistry, we examined the expression of the Ca2+-binding protein S100B in the dentate gyrus of adult rats during lesion-induced sprouting and reactive synaptogenesis. Nine days following unilateral lesioning of the entorhinal cortex, S100B was upregulated in cells primarily in the outer part of the molecular layer of the ipsilateral dentate gyrus. When examined with electron microscopy, numerous astrocytes and synapses containing S100B were identified. These data show that during lesion-induced sprouting and reactive synaptogenesis, S100B is upregulated in astrocytes and can be found in pre- and post-synaptic compartments where it might influence neuronal protein phosphorylation. Copyright 1998 Published by Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9824701     DOI: 10.1016/s0006-8993(98)01014-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  13 in total

1.  S100B-mediated inhibition of the phosphorylation of GFAP is prevented by TRTK-12.

Authors:  Juliana Karl Frizzo; Francine Tramontina; Erica Bortoli; Carmen Gottfried; Rodrigo B Leal; Imre Lengyel; Rosario Donato; Peter R Dunkley; Carlos-Alberto Gonçalves
Journal:  Neurochem Res       Date:  2004-04       Impact factor: 3.996

2.  S100B and Glial Fibrillary Acidic Protein as Indexes to Monitor Damage Severity in an In Vitro Model of Traumatic Brain Injury.

Authors:  Valentina Di Pietro; Angela Maria Amorini; Giacomo Lazzarino; Kamal Makram Yakoub; Serafina D'Urso; Giuseppe Lazzarino; Antonio Belli
Journal:  Neurochem Res       Date:  2015-04-22       Impact factor: 3.996

Review 3.  Strategies targeting endogenous neurogenic cell response to improve recovery following traumatic brain injury.

Authors:  Kaushal Patel; Dong Sun
Journal:  Brain Res       Date:  2016-02-08       Impact factor: 3.252

4.  Release of biochemical markers of damage to neuronal and glial brain tissue is associated with short and long term neuropsychological outcome after traumatic brain injury.

Authors:  M Herrmann; N Curio; S Jost; C Grubich; A D Ebert; M L Fork; H Synowitz
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-01       Impact factor: 10.154

5.  Association of CSF biomarkers and secondary insults following severe traumatic brain injury.

Authors:  Deborah M Stein; Joseph A Kufera; Allison Lindell; Karen R Murdock; Jay Menaker; Grant V Bochicchio; Bizhan Aarabi; Thomas M Scalea
Journal:  Neurocrit Care       Date:  2011-04       Impact factor: 3.210

6.  The Passage of S100B from Brain to Blood Is Not Specifically Related to the Blood-Brain Barrier Integrity.

Authors:  Andrea Kleindienst; Christian Schmidt; Hans Parsch; Irene Emtmann; Yu Xu; Michael Buchfelder
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-07-08

7.  Targeting S100B in Cerebral Ischemia and in Alzheimer's Disease.

Authors:  Takashi Mori; Takao Asano; Terrence Town
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-09-02

8.  Serum S100B levels after meningioma surgery: A comparison of two laboratory assays.

Authors:  Eyal Itshayek; Jeremy D Kark; Haim Ovadia; Carolyn F Weiniger; Yigal Shoshan; Sharon Einav
Journal:  BMC Clin Pathol       Date:  2008-09-19

9.  6-OHDA-Induced Changes in Parkinson's Disease-Related Gene Expression are not Affected by the Overexpression of PGAM5 in In Vitro Differentiated Embryonic Mesencephalic Cells.

Authors:  Tomasz Maciej Stępkowski; Iwona Wasyk; Agnieszka Grzelak; Marcin Kruszewski
Journal:  Cell Mol Neurobiol       Date:  2015-05-19       Impact factor: 5.046

10.  Serum protein mediators of dementia and aging proper.

Authors:  Donald R Royall; Safa Al-Rubaye; Ram Bishnoi; Raymond F Palmer
Journal:  Aging (Albany NY)       Date:  2016-12-03       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.